uniQure Inc.

Contributing Author

Recent Articles by uniQure Inc.

6 hours	uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease QURE GlobeNewswire
May-29	uniQure Presents Clinical Case Study of First Patient Dosed with AMT-260 in Refractory Mesial Temporal Lobe Epilepsy (MTLE) QURE GlobeNewswire
May-09	uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress QURE GlobeNewswire
May-05	uniQure to Announce First Quarter 2025 Financial Results QURE GlobeNewswire